Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof

Factor XI antibodies and methods of use

Immunoactivating antigen-binding molecule

Multispecific GITR-binding fusion proteins and methods of use thereof

Humanized anti-CD70 binding agents and uses thereof

Prolactin receptor binding proteins and uses thereof

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

Antibodies that bind to MHC class I polypeptide-related sequence A

T-cell redirecting bispecific antibodies for treatment of disease

Antibody therapeutics that bind LAG3

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS

ANTIGEN-BINDING MOLECULE PROMOTING DISAPPEARANCE OF ANTIGENS HAVING PLURALITY OF BIOLOGICAL ACTIVITIES

Anti-Aβ globulomer 4D10 antibodies

Antibodies specific to pyroglutamated Aβ

METHODS FOR SYSTEMATIC CONTROL OF PROTEIN STABILITY

Carrier-antibody compositions and methods of making and using the same

Carrier-antibody compositions and methods of making and using the same

SYSTEM AND METHOD FOR IMPROVED TRANSIENT PROTEIN EXPRESSION IN CHO CELLS

Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same

Anti-fibulin-3 antibodies and uses thereof

NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A

Nucleic acids encoding antibody polypeptides that antagonize CD40

Multivalent and multispecific DR5-binding fusion proteins

Antibodies against human CSF-1R and uses thereof

ACTRIIA BINDING AGENTS AND USES THEREOF

Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

Anti-erythropoietin antibodies

Antibodies against platelet-derived growth factor (PDGF)

Agents, uses and methods for the treatment of synucleinopathy

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Anti-transthyretin antibodies

Anti-glucosaminidase passive immunization for infections

Compositions and methods for treating and preventing infections

Antibody-drug conjugates and uses thereof

ANTI-NOTCH3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

AURISTATIN-ANTIBODY CONJUGATES AND USES THEREOF

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Antibodies comprising C-terminal light chain polypeptide extensions and conjugates and methods of use thereof

Anti-TLR4 antibodies and uses thereof

ANTIBODY DRUG CONJUGATES

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

Therapeutic peptides

Oncostatin M receptor antigen binding proteins

HUMANIZED BETA-AMYLOID BINDING MOLECULES AND USES THEREOF

Means and methods for producing stable antibodies

Antibody-drug conjugates and immunotoxins

Assay for methoxetamine

METHODS AND MATERIALS FOR ASSESSING ENZYME-NUCLEIC ACID COMPLEXES

Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema

Anti-MCAM antibodies and associated methods of use

COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES

Activatable antibodies that bind interleukin-6 receptor and methods of use thereof

Antibody against the CSF-1R

Antibodies With Modified Affinity To FcRn That Promote Antigen Clearance

ST2 antigen binding proteins

Methods of treating ulcerative colitis

TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF

Anti-CD33 antibodies and immunoconjugates

Human IL-23 antigen binding proteins

Polypeptides

Anti-C5a binding moieties with high blocking activity

Antibodies With Modified Affinity To FcRn That Promote Antigen Clearance

Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications

scFV antibody library

PROTEINS COMPRISING BINDING REGIONS, SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS, AND CARBOXY-TERMINAL, ENDOPLASMIC RETICULUM LOCALIZATION SIGNAL MOTIFS

Anti-DLL3 antibody drug conjugates for treating cancer

Therapeutic biologic for treatment of hepatocellular carcinoma

Anti-KRS monoclonal antibody and use thereof

Vectors for use in an inducible coexpression system

ANTIBODIES TO CEACAM1 AND KINASE INHIBITORS FOR TREATING BRAF-MUTATED CELLS

Antibodies to CD40 with enhanced agonist activity

Interferon receptor 1 antibodies and their uses

Anti-EphA2 antibodies and methods of use thereof

PD-1 antibody, antigen-binding fragment thereof, and medical application thereof

Humanized anti-CD22 antibody

Tight-binding agents and uses thereof

METHOD OF TREATING CANCER

Methods of determining whether anti-PACAP (adenylate cyclase-activating peptide) antibodies or anti-PACAP antigen binding fragments inhibit PACAP-associated photophobia or light aversion

Use of an IL-17/IL-23 bispecific antibody for treating inflammation

IL-18 binding molecules

Anti-human proBDNF monoclonal antibody, and uses thereof in pains

Human antibodies to fel D1 and methods of use thereof

Methods of producing anti-C5a antibodies

Antigen associated with lung cancers and lymphomas

Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereof

HUMANIZED, ANTI-N2 ANTIBODIES

Humanized anti-tau(pS422) antibodies and methods of use

Anti-Tau antibodies and methods of use

Fc fusion proteins comprising novel linkers or arrangements

PROTEINS COMPRISING AMINO-TERMINAL PROXIMAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS AND CELL-TARGETING IMMUNOGLOBULIN-TYPE BINDING REGIONS

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity

High-throughput mouse model for optimizing antibody affinities

CYS80 conjugated immunoglobulins

Anti-PCSK9-GLP-1 fusions and methods for use

Humanised anti kallikrein-2 antibody

Fc-ENHANCED ANTI-WT1/HLA ANTIBODY

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Multispecific NK engager proteins

4-1BB BINDING MOLECULES

FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB

Anti-OX40L antibodies and methods of treating graft versus host disease

Anti-CLL-1 antibodies and methods of use

Anti-CTLA-4 antibodies and methods of use thereof

Human CD3 binding antibody

BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DISEASES

Humanized and affinity matured antibodies to FcRH5 and methods of use

Compositions comprising antibodies to LINGO or fragments thereof

Human anti-IL-32 antibodies and methods of making and using the same

Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide

Methods for treating pain using antibodies to Kallidin and des-Arg-Kallidin

Anti-complement factor C1q antibodies and uses thereof

Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein

Variant target binding agents and uses thereof

POLYPEPTIDE CONSTRUCTS AND USES THEREOF

Method of treating cancer using IL2R beta/common gamma chain antibodies

Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein

Polynucleotides encoding VEGF/DLL4 binding agents

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Methods of detecting a tumor expressing fibroblast growth factor receptor 2

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

ICOS binding proteins

Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same

Methods of treating an inflammatory condition or sensitivity to an allergen with anti-IL-33 antibodies

Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

KIDNEY DISEASE TARGETS AND USES THEREOF

Multi-specific polypeptide useful for localized tumor immunomodulation

Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia

Methods for reducing immune responses

ANTIBODIES THAT BIND TO HUMAN TAU AND ASSAY FOR QUANTIFYING HUMAN TAU USING THE ANTIBODIES

Heterodimeric antibodies that bind CD3 and tumor antigens

CA6 antigen-specific cytotoxic conjugate and methods of using the same

Cancer therapy using CLDN6 target-directed antibodies in vivo

Bispecific antibody binding to human TLR2 and human TLR4

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

Antibody molecules having specificity for human OX40

CX3CR1-binding polypeptides

Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof

Lym-1 and Lym-2 targeted CAR cell immunotherapy

ANTI-TIGIT ANTIBODIES

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

Antagonists of IL-6 to raise albumin and/or lower CRP

Antibodies targeting bone morphogenetic protein 9 (BMP9) and methods therefor

Methods of treating a tauopathy

Methods and compositions for targeting polyubiquitin

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

Oligopeptide and methods for producing conjugates thereof

Humanized anti-complement factor C1Q antibodies

Immunoglobulin constant region Fc receptor binding agents

Compositions for inducing antigen-specific tolerance

Methods for induction of antigen-specific immune tolerance

Compositions for generating immune tolerance by targeting erythrocytes

Fluoroimmunoassay Method

Acceptor framework for CDR grafting

Anti human Notch4 antibody

TLR3 BINDING AGENTS

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

Anti-CD40 antibodies

Antibodies against OX40 and uses thereof

Anti-OX40 antibodies

Polynucleotides encoding an actriib antibody

Isoform specific soluble FMS-like tyrosine kinase (sFlt) binding agents and uses thereof

Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof

Antibodies comprising chimeric constant domains

OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION

Anti-transthyretin humanized antibody

Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof

Immunoglobulin against the anthrax toxin

Antibodies against F glycoprotein of Hendra and Nipah viruses

Optimized Fc variants and methods for their generation

Tau peptides, anti-tau antibodies, and methods of use thereof

Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)

Compositions and methods to modulate cell activity

Animal models and therapeutic molecules

Trispecific binding proteins and methods of use

Anti-mesothelin binding proteins

Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy

OPTIMIZED FC VARIANTS

Human C-FMS antigen binding proteins

Formulation for anti-α4β7 antibody

Methods of treating ulcerative colitis

Immunomodulatory agents

Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and an anti-CTLA-4 antibody

Antibodies to human GDF8

Agents that specifically bind matrilin-3 and their use

ANTIBODIES DIRECTED AGAINST THE LukGH (LukAB) TOXIN OF STAPHYLOCOCCUS AUREUS AND ANTIBODY SEQUENCES

Interleukin-10 fusion proteins and uses thereof

Carrier-antibody compositions and methods of making and using the same

Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies

BACTERIAL INFLUENCE OF HOST FEEDING AND EMOTION VIA CLPB PROTEIN MIMICRY OF A-MSH

Carrier-antibody compositions and methods of making and using the same

Anti-tissue factor monoclonal antibody

Anti-human TROP-2 antibody having an antitumor activity in vivo

CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE

Anti-FZD10 monoclonal antibodies and methods for their use

Multivalent antibodies

Antibodies against TL1a and uses thereof

Baff selective binding compounds and related methods

Anti-human RANKL antibody, humanized antibody of the same, and pharmaceutical composition and use thereof

Methods for the preparation of compounds directed against interleukin-6 receptor (IL-6R)

Antibodies against canine PD-1

Humanized or chimeric CD3 antibodies

Anti-IL-23 antibodies

Antibodies directed against interleukin-33 (IL-33) and methods of making and using

Antigenic GM-CSF peptides and antibodies to GM-CSF

Antigen binding proteins

Targeting CLPTM1L for treatment and prevention of cancer

Antibody targeting cell surface deposited complement protein C3d and use thereof

AGLYCOSYLATED ANTI-Bb ANTIBODIES AND USES THEREOF

AGLYCOSYLATED ANTI-C3b ANTIBODIES AND USES THEREOF

Antibodies specific for enteroviruses that infect humans

Antibody therapeutics that bind PSMA

CD37-binding molecules and immunoconjugates thereof

NOVEL ANTI ADAM17 ANTIBODY AND ITS USE FOR THE TREATMENT OF CANCER

Recombinant obligate anaerobic gram-positive bacteria

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies

BIOLOGICAL PRODUCTS

Use of IL-1 β binding antibodies for treating peripheral arterial disease

TNFa-IL-17 bispecific antibodies

Aβ conformer selective anti-Aβ globulomer monoclonal antibodies

METHODS OF TREATMENT FOR GUILLAIN-BARRE SYNDROME

Antibody possessing an affinity for epithelial secretory and nervous tissue, as well as tumour tissue derived from these tissues as well as the use thereof

Methods of preparation of conjugates

Nanoparticle complexes of albumin, paclitaxel, and panitumumab for treatment of cancer

Transgenic transchromosomal rodents for making human antibodies

Antibody identification by lineage analysis

Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1

MET-BINDING AGENTS AND USES THEREOF

Neuregulin allosteric anti-HER3 antibody

Neutralizing prolactin receptor antibody Mat3 and its therapeutic use

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Anti-human BDCA-2 antibody

Anti-CD19 antibodies

Anti-PD-1 antibodies

Caninized murine antibodies to human PD-1

Antibodies to tumor endothelial marker 8

Adrenomedullin binder for use in therapy of cancer

Anti-aP2 antibodies and antigen binding agents to treat metabolic disorders

Optimized Fc variants and methods for their generation

Chimeric virus-like particles incorporating fusion GPI anchored GM-CSF and IL-4 conjugates

Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2) antibody and a tyrosine kinase inhibitor

Dual specificity antibody fusions

Polynucleotides encoding anti-kit antibodies

Antigen binding proteins that bind ErbB3

Human mesothelin chimeric antigen receptors and uses thereof

Anti-CD40 antibodies

Methods for treating or preventing migraine headache

ANTI-GLUCAGON RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

Compositions and methods for inhibiting PDGFRbeta and VEGF-A

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof

Caninized antibodies

Histidine engineered light chain antibodies and genetically modified non-human animals for generating same

IL-31 monoclonal antibody formulations

Monoclonal antibodies that bind both IL-17A and IL-17F

Anti-Complement factor H antibodies

Nanoparticle complexes of anti-CD20 antibodies, albumin and paclitaxel

Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules

Directed evolution of multivalent glycopeptides that tightly bind to target proteins

Peptides and uses thereof

Multivalent glycopeptides that tightly bind to target proteins

ACCEPTOR FRAMEWORK FOR CDR GRAFTING

Anti-HER2 antibody and conjugate thereof

ANTIBODIES FOR DIAGNOSIS OF ACUTE MYELOID LEUKEMIA

Anti-EGFRvIII antibodies and uses thereof

NEUROPILIN ANTAGONISTS

Antibodies to ICOS

Antibodies to human programmed death receptor PD-1

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

Anti-PACAP antibodies

HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS

Anti-PHF-tau antibodies and their uses

Nucleic acids encoding anti-polyubiquitin antibodies

Methods of diagnosing tau-protein-associated disease

Optimized Fc variants

PERTUSSIS ANTIBODIES AND USES THEREOF

Insertable variable fragments of antibodies and modified α1-α2 domains of NKG2D ligands

Antibody-SN-38 immunoconjugates with a CL2A linker

Anti-TROP2 antibody-drug conjugate

Antibody therapeutics that bind CD38

Engineered immunoglobulin Fc polypeptides displaying improved complement activation

Therapeutic antibodies and their uses

Chimeric antigen receptors targeting B-cell maturation antigen

Methods of treating neuropathic pain with specific binding members for NGF

Anti-pseudomonas Psl binding molecules and uses thereof

Inhibitors of type 2 vascular endothelial growth factor receptors

Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer

HCV core lipid binding domain monoclonal antibodies

Fabs-in-tandem immunoglobulin and uses thereof

Anti-CD20− / anti-BAFF bispecific antibodies

Fabs-in-tandem immunoglobulin and uses thereof

Compositions and methods for treatment and detection of cancers

Antibodies

Polypeptides

CANCER BIOMARKERS AND USES THEREOF

Bispecific antigen-binding constructs targeting HER2

Anti-claudin antibodies and methods of use